Cargando…
Anagrelide Modulates Proplatelet Formation Resulting in Decreased Number and Increased Size of Platelets
We retrospectively evaluated 48 essential thrombocythemia (ET) patients who were treated in our institute (male/female, 14/34, median age, 61.5 years). In 14 patients treated with anagrelide (ANA), the degree of platelet count reduction (median, −56.6%) was strongly correlated with increase of mean...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745917/ https://www.ncbi.nlm.nih.gov/pubmed/31723843 http://dx.doi.org/10.1097/HS9.0000000000000268 |